Rapamycin

An intermittent rapamycin protocol used as a geroprotective intervention, commonly taken at 8 mg once per week rather than daily. One described pattern is about two months on followed by one month off to reduce aphthous ulcers/canker sores. The appeal is its reputation as a strong longevity-focused molecule, with the dosing schedule aimed at preserving the anti-aging signal while improving tolerability.